US 6869604
Recombinant anti-tumor RNAse
expired A61KA61K38/00A61K47/6815
Quick answer
US patent 6869604 (Recombinant anti-tumor RNAse) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Mar 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K38/00, A61K47/6815